@article{49d6ae3747054b4aa28ec7e67dc217c4,
title = "COVID-19 diagnostic assays sensitivity: lessons for the upcoming wave or next pandemic",
keywords = "assay sensitivity, COVID-19, diagnostic assays, next wave, NGS, pandemic, RT-PCR",
author = "Sahahjpal, {Nikhil Shri} and Mondal, {Ashis K} and Sudha Ananth and Kimya Jones and Alka Chaubey and Ravindra Kolhe",
note = "Funding Information: R Kolhe has received honoraria, travel funding, and research support from Illumina, Asuragen, Bionano Genomics, PerkinElmer Inc. QIAGEN, and BMS. A Chaubey is a salaried employee at Bionano Genomics Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.",
year = "2021",
month = oct,
doi = "10.4155/fmc-2021-0209",
language = "English (US)",
volume = "13",
pages = "1713--1715",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
publisher = "Future Science",
number = "20",
}